S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
SOLV · Solventum Corporation
NEW YORK STOCK EXCHANGE, INC. - BOATS Real Time Price • USD
$86.66
+0.28
(+0.33%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$86.66
$85.79
$86.76
52-WEEK RANGE
$86.66
$62.38
$94.16
What's happening
- SOLV is up 0.33% today, trading at $86.66. — Live quote
- Volume today (46,069) is well below its 3-month average of 1,107,090. (Finnhub fundamentals)
- Reports earnings on 2026-11-05, 14 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $2.55 actual vs. $1.94 estimated (+31.2%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 6
Buy 7
Hold 8
Sell 1
Strong sell 0
Aggregate ratings for 2026-10-01 (22 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
SOLV
+9.02%
vs S&P 500
-3.75%
1-YEAR RETURN
SOLV
+18.55%
vs S&P 500
+3.99%
6-MONTH RETURN
SOLV
+25.42%
3-MONTH RETURN
SOLV
+9.91%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$2.55
Est. $1.94
BEAT +31.2%
2026-04-26 (Q1 2026)
$1.48
Est. $1.38
BEAT +7.3%
2026-01-26 (Q4 2025)
$1.57
Est. $1.53
BEAT +2.9%
2025-10-26 (Q3 2025)
$1.50
Est. $1.46
BEAT +2.7%
Valuation Measures & Ratios
Enterprise Value4$19.59B
Forward P/E512.11
PEG Ratio60.04
Price / Sales (TTM1)1.77
Price / Book72.78
EV4 / Revenue2.36
EV4 / EBITDA7.87
Profit Margin17.27%
Operating Margin23.86%
Return on Equity (ROE8)28.98%
Return on Assets (ROA9)10.14%
Avg Volume (3M)1,107,090
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $13.39B | $12.13B | $12.80B | $13.38B | $13.36B |
| P/E | 9.16 | 8.05 | 7.93 | 30.56 | 22.83 |
| Price/Sales | 1.58 | 1.46 | 1.52 | 1.59 | 1.62 |
| Price/Book | 2.79 | 2.44 | 2.57 | 3.67 | 4.09 |
| EV/Revenue | 2.07 | 1.94 | 1.94 | 2.47 | 2.50 |
| EV/EBITDA | 6.56 | 6.10 | 5.75 | — | — |
| ROE | 30.44% | 30.31% | 32.39% | 12.02% | 17.93% |
| ROA | 10.26% | 10.68% | 11.56% | 2.91% | 4.03% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short4,894,684
Change from Prior Settlement+0.66%
% of Float—
Days to Cover (Short Ratio)5.43
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 2.2% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is 17.3%. Finnhub fundamentals ↗
- Trailing 52-week price return is +18.6%. Finnhub market metrics ↗
Potential concerns
- Latest SEC filing is Form 4, filed 2026-09-03; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on SOLV
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.21B | $2.01B | $2.10B | $2.16B | $2.07B | $2.08B | $2.08B | $2.02B |
| Gross profit | $1.29B | $1.10B | $1.14B | $1.18B | $1.11B | $1.17B | $1.14B | $1.17B |
| Operating income | $181.0M | $81.0M | $1.69B | $214.0M | $152.0M | $275.0M | $244.0M | $381.0M |
| Net income | $92.0M | $13.0M | $1.27B | $90.0M | $137.0M | $122.0M | $89.0M | $237.0M |
| EPS (diluted) | $0.53 | $0.07 | $7.22 | $0.51 | $0.78 | $0.70 | $0.51 | $1.37 |
| EPS (basic) | $0.53 | $0.07 | $7.26 | $0.52 | $0.79 | $0.70 | $0.51 | $1.37 |
| Operating margin | $8 | $4 | $81 | $10 | $7 | $13 | $12 | $19 |
| Net margin | $4 | $1 | $60 | $4 | $7 | $6 | $4 | $12 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $14.24B | $14.10B | $14.29B | $13.97B | $15.07B | $14.53B | $14.46B | $14.74B |
| Total liabilities | $9.44B | $9.13B | $9.24B | $8.99B | $11.43B | $11.27B | $11.50B | $11.55B |
| Stockholders' equity | $4.80B | $4.97B | $5.05B | $4.99B | $3.65B | $3.26B | $2.96B | $3.19B |
| Total current assets | $3.74B | $3.58B | $3.86B | $4.41B | $3.21B | $3.05B | $3.25B | $3.35B |
| Total current liabilities | $3.66B | $3.35B | $3.14B | $2.94B | $2.62B | $2.57B | $2.70B | $2.90B |
| Cash & equivalents | $403.0M | $561.0M | $878.0M | $1.64B | $492.0M | $534.0M | $762.0M | $772.0M |
| Accounts receivable | $1.31B | $1.06B | $1.03B | $1.02B | $1.06B | $926.0M | $1.04B | $1.10B |
| Inventory | $1.04B | $1.09B | $1.07B | $1.05B | $962.0M | $866.0M | $965.0M | $953.0M |
| Other current assets | $865.0M | $754.0M | $731.0M | $540.0M | $331.0M | $249.0M | $293.0M | $302.0M |
| Property, plant & equipment | — | — | $1.33B | $1.34B | $1.31B | $1.20B | $1.62B | $1.60B |
| Goodwill | $5.63B | $5.63B | $5.70B | $5.26B | $5.27B | $4.99B | $6.38B | $6.59B |
| Intangible assets | $2.41B | $2.50B | $2.59B | $2.22B | $2.30B | $2.37B | $2.54B | $2.65B |
| Other non-current assets | $904.0M | $848.0M | $814.0M | $747.0M | $917.0M | $814.0M | $665.0M | $549.0M |
| Accounts payable | $701.0M | $699.0M | $687.0M | $669.0M | $643.0M | $604.0M | $618.0M | $560.0M |
| Accrued liabilities | $331.0M | $337.0M | $435.0M | $464.0M | $355.0M | $356.0M | $272.0M | $450.0M |
| Deferred revenue (current) | $596.0M | $613.0M | $621.0M | $576.0M | $557.0M | $558.0M | $572.0M | $563.0M |
| Short-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current liabilities | $1.53B | $1.19B | $1.39B | $1.23B | $1.01B | $891.0M | $1.04B | $1.03B |
| Long-term debt | $4.57B | $4.58B | $5.04B | $5.14B | $7.82B | $7.81B | $7.81B | $7.81B |
| Other non-current liabilities | $486.0M | $478.0M | $547.0M | $437.0M | $371.0M | $279.0M | $410.0M | $305.0M |
| Common stock & paid-in capital | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M |
| Retained earnings | $1.90B | $1.81B | $1.80B | $1.73B | $468.0M | $378.0M | $242.0M | $211.0M |
| Accumulated other comprehensive income (loss) | -$669.0M | -$670.0M | -$625.0M | -$604.0M | -$631.0M | -$899.0M | -$1.06B | -$765.0M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $227.0M | -$189.0M | $95.0M | $76.0M | $169.0M | $29.0M | $219.0M | $169.0M |
| Investing cash flow | -$87.0M | -$77.0M | -$745.0M | $3.77B | -$110.0M | -$114.0M | -$127.0M | -$93.0M |
| Financing cash flow | -$300.0M | -$50.0M | -$115.0M | -$2.69B | -$110.0M | -$139.0M | -$104.0M | -$202.0M |
| Free cash flow | $144.0M | -$273.0M | $32.0M | -$21.0M | $59.0M | -$80.0M | $92.0M | $76.0M |
| Capital expenditures | $83.0M | $84.0M | $63.0M | $97.0M | $110.0M | $109.0M | $127.0M | $93.0M |
| Depreciation & amortization | $133.0M | $135.0M | $117.0M | $121.0M | $122.0M | $129.0M | $150.0M | $133.0M |
| Share-based compensation | $38.0M | $51.0M | $37.0M | $41.0M | $34.0M | $49.0M | $25.0M | $27.0M |
| Deferred income taxes | -$47.0M | -$41.0M | -$73.0M | $130.0M | -$33.0M | -$144.0M | -$62.0M | -$37.0M |
| Change in accounts receivable | $252.0M | $34.0M | $2.0M | -$51.0M | $21.0M | -$6.0M | -$29.0M | $56.0M |
| Change in inventory | -$50.0M | $32.0M | $5.0M | $57.0M | $45.0M | $32.0M | $33.0M | $42.0M |
| Change in accounts payable | $3.0M | $23.0M | $30.0M | $51.0M | $14.0M | $9.0M | $66.0M | $68.0M |
| Other investing activities | $4.0M | -$7.0M | $6.0M | $7.0M | $0 | $5.0M | $0 | $0 |
| Share repurchases | $288.0M | $67.0M | — | — | $0 | $0 | — | — |
| Other financing activities | -$13.0M | -$31.0M | -$3.0M | $68.0M | -$11.0M | -$8.0M | $0 | -$2.0M |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|
| Revenue | $8.32B | $8.25B | $8.20B | $8.13B |
| Gross profit | $4.45B | $4.59B | $4.69B | $4.70B |
| Operating income | $2.18B | $1.04B | $1.69B | $1.69B |
| Net income | $1.56B | $479.0M | $1.35B | $1.34B |
| EPS (diluted) | $8.88 | $2.76 | $7.79 | $7.78 |
| EPS (basic) | $8.94 | $2.77 | $7.79 | $7.78 |
| Operating margin | $26 | $13 | $21 | $21 |
| Net margin | $19 | $6 | $16 | $17 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $14.29B | $14.46B | $13.94B | — | — |
| Total liabilities | $9.24B | $11.50B | $2.28B | — | — |
| Stockholders' equity | $5.05B | $2.96B | $11.67B | $11.74B | $12.06B |
| Total current assets | $3.86B | $3.25B | $2.52B | — | — |
| Total current liabilities | $3.14B | $2.70B | $1.73B | — | — |
| Cash & equivalents | $878.0M | $762.0M | $194.0M | — | — |
| Accounts receivable | $1.03B | $1.04B | $1.31B | — | — |
| Inventory | $1.07B | $965.0M | $857.0M | — | — |
| Other current assets | $731.0M | $293.0M | $155.0M | — | — |
| Property, plant & equipment | $1.33B | $1.62B | $1.46B | — | — |
| Goodwill | $5.70B | $6.38B | $6.54B | $6.43B | — |
| Intangible assets | $2.59B | $2.54B | $2.90B | — | — |
| Other non-current assets | $814.0M | $665.0M | $530.0M | — | — |
| Accounts payable | $687.0M | $618.0M | $477.0M | — | — |
| Accrued liabilities | $435.0M | $272.0M | $0 | — | — |
| Deferred revenue (current) | $621.0M | $572.0M | $574.0M | — | — |
| Short-term debt | $0 | $0 | — | — | — |
| Other current liabilities | $1.39B | $1.04B | $677.0M | — | — |
| Long-term debt | $5.04B | $7.81B | $0 | — | — |
| Other non-current liabilities | $547.0M | $410.0M | $152.0M | — | — |
| Common stock & paid-in capital | $2.0M | $2.0M | $0 | — | — |
| Retained earnings | $1.80B | $242.0M | $0 | — | — |
| Accumulated other comprehensive income (loss) | -$625.0M | -$1.06B | -$337.0M | — | — |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|
| Operating cash flow | $369.0M | $1.19B | $1.92B | $1.68B |
| Investing cash flow | $2.80B | -$380.0M | -$230.0M | -$253.0M |
| Financing cash flow | -$3.06B | -$240.0M | -$1.55B | -$1.46B |
| Free cash flow | -$10.0M | $805.0M | $1.62B | $1.43B |
| Capital expenditures | $379.0M | $380.0M | $290.0M | $251.0M |
| Depreciation & amortization | $489.0M | $555.0M | $561.0M | $578.0M |
| Share-based compensation | $161.0M | $112.0M | $39.0M | $37.0M |
| Deferred income taxes | -$120.0M | -$155.0M | -$142.0M | -$141.0M |
| Change in accounts receivable | -$34.0M | -$43.0M | $129.0M | $32.0M |
| Change in inventory | $139.0M | $132.0M | -$23.0M | $82.0M |
| Change in accounts payable | $104.0M | $266.0M | $105.0M | $25.0M |
| Other investing activities | $18.0M | $0 | $0 | $2.0M |
| Other financing activities | $46.0M | $8.0M | $1.0M | -$4.0M |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding SOLV as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-04-30 to 2026-09-01
Recent transactions
- Most recent: Hanson Bryan C (Chief Executive Officer) — Option exercise of 67,261 shares on 2026-09-01.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)0 sh(0 txns)
Net Shares+0
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Hanson Bryan C | Chief Executive Officer | Option exercise | 2026-09-01 | 67,261 |
| Gomez Tammy L | Chief Human Resources Officer | Option exercise | 2026-05-13 | 3,960 |
| McMillan Wayde D. | Chief Financial Officer | Option exercise | 2026-05-13 | 9,503 |
| Harrington Paul S | Chief Supply Chain Officer | Option exercise | 2026-05-13 | 3,960 |
| Wilcox Mary T | Chief Accounting Officer | Option exercise | 2026-05-13 | 2,376 |
| Kirberger Marcela A. | Chief Legal Affairs Officer | Option exercise | 2026-05-13 | 4,488 |
| Landucci Amy | Chief Information Officer | Option exercise | 2026-05-13 | 4,422 |
| Wendell Amy McBride | Director | Option exercise | 2026-04-30 | 3,403 |
| WEILAND JOHN H | Director | Option exercise | 2026-04-30 | 3,403 |
| Mily Elizabeth | Director | Option exercise | 2026-04-30 | 3,403 |
| Wilson Darryl L. | Director | Option exercise | 2026-04-30 | 3,403 |
| MAY KAREN J | Director | Option exercise | 2026-04-30 | 3,403 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-01 | Hanson Bryan C | Chief Executive Officer | Option exercise | 67,261 | — |
| 2026-09-01 | Hanson Bryan C | Chief Executive Officer | Tax withholding | 26,468 | $90.95 |
| 2026-05-13 | Gomez Tammy L | Chief Human Resources Officer | Option exercise | 3,960 | $0.00 |
| 2026-05-13 | Gomez Tammy L | Chief Human Resources Officer | Tax withholding | 1,668 | $74.41 |
| 2026-05-13 | McMillan Wayde D. | Chief Financial Officer | Option exercise | 9,503 | $0.00 |
| 2026-05-13 | McMillan Wayde D. | Chief Financial Officer | Tax withholding | 4,404 | $74.41 |
| 2026-05-13 | Harrington Paul S | Chief Supply Chain Officer | Option exercise | 3,960 | $0.00 |
| 2026-05-13 | Harrington Paul S | Chief Supply Chain Officer | Tax withholding | 1,678 | $74.41 |
| 2026-05-13 | Wilcox Mary T | Chief Accounting Officer | Option exercise | 2,376 | $0.00 |
| 2026-05-13 | Wilcox Mary T | Chief Accounting Officer | Tax withholding | 728 | $74.41 |
| 2026-05-13 | Kirberger Marcela A. | Chief Legal Affairs Officer | Option exercise | 4,488 | $0.00 |
| 2026-05-13 | Kirberger Marcela A. | Chief Legal Affairs Officer | Tax withholding | 1,952 | $74.41 |
| 2026-05-13 | Hanson Bryan C | Chief Executive Officer | Option exercise | 34,315 | $0.00 |
| 2026-05-13 | Hanson Bryan C | Chief Executive Officer | Tax withholding | 13,503 | $74.41 |
| 2026-05-13 | Landucci Amy | Chief Information Officer | Option exercise | 4,422 | $0.00 |
| 2026-05-13 | Landucci Amy | Chief Information Officer | Tax withholding | 2,017 | $74.41 |
| 2026-04-30 | Wendell Amy McBride | Director | Option exercise | 3,403 | $0.00 |
| 2026-04-30 | WEILAND JOHN H | Director | Option exercise | 3,403 | $0.00 |
| 2026-04-30 | Mily Elizabeth | Director | Option exercise | 3,403 | $0.00 |
| 2026-04-30 | Wilson Darryl L. | Director | Option exercise | 3,403 | $0.00 |
| 2026-04-30 | MAY KAREN J | Director | Option exercise | 3,403 | $0.00 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 04:28 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-09-03 | 4 | 2026-09-01 | View on SEC.gov → |
| 2026-08-18 | 4 | 2026-08-17 | View on SEC.gov → |
| 2026-08-05 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-05 | 8-K | 2026-08-05 | View on SEC.gov → |
| 2026-08-05 | 8-K | 2026-08-05 | View on SEC.gov → |
| 2026-07-20 | 8-K | 2026-07-16 | View on SEC.gov → |
| 2026-06-05 | 8-K | 2026-06-02 | View on SEC.gov → |
| 2026-05-27 | 8-K | 2026-05-21 | View on SEC.gov → |
| 2026-05-20 | 8-K | 2026-05-15 | View on SEC.gov → |
| 2026-05-18 | 4 | 2026-05-15 | View on SEC.gov → |
| 2026-05-18 | 4 | 2026-05-15 | View on SEC.gov → |
| 2026-05-18 | 4 | 2026-05-15 | View on SEC.gov → |
Recent news
Headlines about SOLV (Solventum Corporation). Links open the publisher — we don’t host full articles.
-
Top SOLV Energy (MWH) Competitors 2026
MarketBeat · 2026-10-21 -
Elevance Health (ELV) Surpasses Q3 Earnings and Revenue Estimates
Yahoo · 2026-10-21 -
Solventum Corporation (SOLV) stock price, news, quote and history
Yahoo Finance Singapore · 2026-10-20 -
Solventum Corp. stock rises Tuesday, outperforms market
MarketWatch · 2026-10-20 -
Solventum Corporation (SOLV) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-20 -
Solventum schedules November 5 results: Solventum stock has USD 14.5 billion value
AD HOC NEWS · 2026-10-20 -
Does FDA Wound Care Clearance Change The Bull Case For Solventum Stock (SOLV)?
Simply Wall Street · 2026-10-20 -
Solventum Announces FDA 510(k) Clearance for Combined Use of Restrata™ Matrix and Solventum™ V.A.C.® Therapy*
Yahoo · 2026-10-19
No headlines in this category right now — try “All”.